Tower Research Capital LLC (Trc) Myriad Genetics Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,876 shares of MYGN stock, worth $51,783. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,876

Previous 29,206 86.73%

Holding current value

$51,783

Previous $714,000 85.15%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $607,160 - $724,438	-25,330 Reduced 86.73%	3,876 $106,000
Q2 2024 Aug 13, 2024	BUY	$17.98 - $25.47 $522,085 - $739,572	29,037 Added 17181.66%	29,206 $714,000
Q1 2024 May 15, 2024	SELL	$17.59 - $23.59 $326,153 - $437,405	-18,542 Reduced 99.1%	169 $3,000
Q4 2023 Feb 13, 2024	BUY	$13.91 - $21.32 $190,094 - $291,359	13,666 Added 270.88%	18,711 $358,000
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $14,470 - $21,014	905 Added 21.86%	5,045 $80,000
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $26,094 - $35,307	1,486 Added 55.99%	4,140 $95,000
Q1 2023 May 09, 2023	BUY	$15.26 - $23.75 $20,234 - $31,492	1,326 Added 99.85%	2,654 $62,000
Q4 2022 Feb 10, 2023	SELL	$14.51 - $20.99 $449,563 - $650,333	-30,983 Reduced 95.89%	1,328 $20,000
Q3 2022 Nov 10, 2022	BUY	$18.21 - $27.88 $104,416 - $159,863	5,734 Added 21.58%	32,311 $616,000
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $280,176 - $440,788	17,032 Added 178.44%	26,577 $483,000
Q1 2022 May 12, 2022	BUY	$22.67 - $28.01 $62,138 - $76,775	2,741 Added 40.29%	9,545 $241,000
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $58,273 - $78,801	-2,415 Reduced 26.2%	6,804 $187,000
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $155,903 - $190,705	5,202 Added 129.5%	9,219 $298,000
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $18,026 - $23,153	-710 Reduced 15.02%	4,017 $122,000
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $53,923 - $85,541	2,707 Added 134.01%	4,727 $144,000
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $18,738 - $30,465	-1,541 Reduced 43.27%	2,020 $40,000
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $201,003 - $263,538	-17,867 Reduced 83.38%	3,561 $46,000
Q2 2020 Aug 13, 2020	BUY	$10.69 - $16.49 $229,065 - $353,347	21,428 New	21,428 $243,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $59,061 - $178,331	-6,039 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$20.93 - $35.1 $126,396 - $211,968	6,039 New	6,039 $164,000
Q3 2019 Nov 05, 2019	SELL	$22.08 - $47.08 $3,267 - $6,967	-148 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$22.67 - $35.0 $3,355 - $5,180	148 New	148 $4,000
Q2 2018 Aug 15, 2018	SELL	$27.75 - $40.17 $36,824 - $53,305	-1,327 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $30,646 - $43,593	1,063 Added 402.65%	1,327 $39,000
Q4 2017 Feb 09, 2018	SELL	$28.45 - $37.14 $126,033 - $164,530	-4,430 Reduced 94.38%	264 $9,000
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $112,702 - $169,922	4,694	4,694 $170,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Myriad Genetics Inc Transaction History